CN Patent

CN118267380B — 呫诺美林-曲司氯铵缓释微球胶囊及其制备方法

Assigned to Beijing Punuo Wang Kang Pharmaceutical Technology Co ltd · Expires 2024-08-27 · 2y expired

What this patent protects

本发明公开了一种呫诺美林‑曲司氯铵缓释微球胶囊及其制备方法。由如下重量百分比的物质组成：呫诺美林4.0%~10.0%、曲司氯铵4.0%~10.0%、丸芯42.0%~56.0%、粘合剂1.5%~3.0%、抗粘剂0.8%~1.5%、缓释材料14.0%~28.0%、致孔剂3.0%~4.5%、增塑剂7.0%~8.0%。本发明制备的微球胶囊可延长药物的释放时间，提高服药方便性和患者顺应性，产品稳定性好，制备工艺简单，易于工业化生产。

USPTO Abstract

本发明公开了一种呫诺美林‑曲司氯铵缓释微球胶囊及其制备方法。由如下重量百分比的物质组成：呫诺美林4.0%~10.0%、曲司氯铵4.0%~10.0%、丸芯42.0%~56.0%、粘合剂1.5%~3.0%、抗粘剂0.8%~1.5%、缓释材料14.0%~28.0%、致孔剂3.0%~4.5%、增塑剂7.0%~8.0%。本发明制备的微球胶囊可延长药物的释放时间，提高服药方便性和患者顺应性，产品稳定性好，制备工艺简单，易于工业化生产。

Drugs covered by this patent

Patent Metadata

Patent number: CN118267380B
Jurisdiction: CN
Classification: —
Expires: 2024-08-27
Drug substance claim: No
Drug product claim: No
Assignee: Beijing Punuo Wang Kang Pharmaceutical Technology Co ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.